Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01801189 · ClinicalTrials.gov registry record · Phase 4

Preoperative Pain Control in Gastric Bypass Surgery Patients

A Phase 4 study of Post Operative Pain, sponsored by Legacy Health System.

Completed
Registry status
Phase 4
Development phase
61
Enrollment target
1
Study location

NCT01801189 is a Phase 4 study of Post Operative Pain that has completed, run by Legacy Health System. The registered enrollment target is 61 participants, below the 235-participant average among 56 other Post Operative Pain trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01801189, a Phase 4 study of Post Operative Pain, has completed, sponsored by Legacy Health System.

COMPLETED
Registry status
Phase 4
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

Randomized clinical trial to evaluate whether a single pre-operative dose of Pregabalin will alleviate post-operative pain and decrease post-operative analgesic requirements in morbidly obese patients undergoing laparoscopic gastric bypass surgery.

Conditions Studied

Interventions

  • DRUG Pregabalin
  • DRUG Placebo (for Pregabalin)

Study Locations (1)

Oregon

  • Legacy Good Samaritan Medical Center - Portland

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2013-02
Est. Completion 2016-01
Phase Phase 4

Sponsor

Legacy Health System

21 total trials

What the Registry Record Tells You About NCT01801189

The ClinicalTrials.gov registry entry for NCT01801189 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 235-participant average among 56 other Post Operative Pain trials with a reported enrollment target (74% lower). The listed sponsor is Legacy Health System, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post Operative Pain appearing as the primary indexed condition, and to 2 interventions - of which Pregabalin is the first listed.

NCT01801189 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT01801189 about?

NCT01801189 is a clinical study titled "Preoperative Pain Control in Gastric Bypass Surgery Patients". Randomized clinical trial to evaluate whether a single pre-operative dose of Pregabalin will alleviate post-operative pain and decrease post-operative analgesic requirements in morbidly obese patients undergoing laparoscopic gastric bypass surgery.

What is the current status of trial NCT01801189?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2013-02. Estimated completion is 2016-01.

What conditions does trial NCT01801189 study?

This clinical trial studies the following conditions: Post Operative Pain.

What interventions are being tested in trial NCT01801189?

The interventions under investigation include: Pregabalin (DRUG), Placebo (for Pregabalin) (DRUG).

Who is sponsoring clinical trial NCT01801189?

This trial is sponsored by Legacy Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01801189 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Operative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.